. Development, validation, and comparison of four methods to simultaneously quantify l-arginine, citrulline, and ornithine in human plasma using hydrophilic interaction liquid chromatography and electrospray tandem mass spectrometry. 
Introduction
This work measures L-arginine in plasma from patients with acute pulmonary embolism (PE). L-arginine is the primary substrate used by endothelial nitric oxide synthase to produce nitric oxide (NO) and L-citrulline. Nitric oxide then diffuses to the vascular smooth muscle, where it functions as the primary vasodilator of pulmonary vasculature; disease conditions that impair the normal steady-state delivery of NO secondarily allow for contraction of vascular smooth muscle. L-arginine can be depleted by either decreased intake or increased destruction, primarily by the action of circulating arginase-I (abundant in erythrocytes), which cleaves L-arginine to form ornithine and urea. Thus, the simultaneous measurement of L-arginine, citrulline and ornithine and their respective ratios, provides mechanistic insight into the cause of L-arginine depletion and subsequent NO lack. Prior work in animals and humans has found that acute pulmonary embolism (PE) causes hemolysis, leading to increased plasma arginase concentrations, with reduced L-arginine concentrations, leading to impaired NO synthesis and pulmonary vasopasm [1] [2] [3] [4] . In the United States, approximately 200,000 individuals are diagnosed with acute pulmonary embolism (PE) each year, resulting in substantial morbidity, primarily related to damage to the right ventricle [5] .
Patients with severe tricuspid regurgitation, implying more severe PE and more hemolysis appear to be at the highest risk of acute L-arginine depletion, and persistent right ventricular dysfunction [6, 7] .
Numerous quantitative methods have been developed and validated to determine a single amino acid of the three [8] . However, fewer methods have been developed and validated for simultaneously quantification of any two of the three amino acids [9, 10] . Among various methods, hydrophilic interaction liquid chromatography (HILIC) columns are gaining popularity due to their simplicity, not requiring traditional derivatization steps or ion-pairing separations for amino acid separation. Currently, only one article has been reported to simultaneously quantify all the three amino acids in plasma or serum using a HILIC column [11] . However, the published method has not been fully validated.
Because the three amino acids are endogenous analytes, true blank matrix for them is not available. Approaches using a surrogate matrix, background subtraction, or a surrogate analyte have been utilized to establish quantification methods for endogenous analytes in different projects [12] [13] [14] . It is necessary and valuable to compare these approaches due to lack of regulatory clarity for validation.
In this study, several approaches have been utilized to establish successful quantification methods. Surrogate matrix is the first choice applied in many projects [15] .
Water and BSA are the most commonly used surrogate matrix. When the plasma with endogenous analytes is used as blank matrix, two strategies have been applied: surrogate analyte approach by spiking of a stable isotope-labeled the analyte as a surrogate standard and background subtraction technique during data processing to handle the spiking of exogenous levels of the analyte. Due to the debate on which approach should be utilized and lack of regulatory clarity for validation of endogenous analytes, we compared four methods: water as blank matrix, 1% BSA in PBS as blank matrix, surrogate analyte, and background subtraction.
In summary, we report the development, validation, and comparison of four methods to simultaneously quantify arginine, citrulline, and ornithine in human clinical plasma using HILIC and tandem mass spectrometry (MS/MS). The established method is expected to be rapid and robust, enabling efficient analysis of large number of clinical plasma samples. 
Materials and methods

Reagents
Patient samples
This study was approved by the Indiana University Institutional Review Board 
Sample preparation
The details of the preparation of standards and quality control samples were described in Supplemental Method 2. Samples were prepared as follows: A 50 μL of each sample was spiked with 10 μL of 200 μM internal standard and incubated at room temperature for 10 min. The samples were extracted with 540 μL of methanol and agitated in an Eppendorf Thermomixer at 1,400 rpm for 3 min followed by centrifugation at 14,000 rcf. 120 μL of supernatant was transferred to a vial and 80 μL of 5 mM ammonium formate were added into the vial. The samples were ready for analysis.
Instrumentation
A Dionex Ultimate 3000 UHPLC system (Sunnyvale, CA) consists of a pump, autosampler, column oven, and UV detector. A SCIEX 4000 QTRAP triple quadrupole mass spectrometer (Toronto, Canada) with a TurboIonSpray probe was used in positive ion mode. SCIEX Analyst 1.5 was used for data collection and SCIEX MutiQuant 3.0.1 was used for peak integration and concentration calculation.
Chromatographic conditions
HPLC separation was performed on a Phenomenex Kinetex HILIC 100A column 
Results and discussions
Sample preparation
Measuring plasma amino acids including arginine, citrulline, and ornithine have been reported with various sample preparation methods based on types of sample and analytical column, especially the analytical column selection. Currently, HILIC columns are gaining popularity due to their simplicity, not requiring traditional derivatization steps or ion-pairing separations for amino acid separation. To analyze one, two, or all of the three amino acids in plasma or serum in one injection using a HILIC column, several sample preparation approaches have been previously reported [10, 11, 16] . However, two issues were observed when the reported methods were followed during our method development. One of them was the choice of the reagent for protein precipitation. The other was the simplicity of sample preparation approaches. Acetonitrile, methanol, and isopropanol are the most commonly used protein precipitation reagents. When acetonitrile was applied initially in the development, it was found that the recovery of all three amino acids was low, especially for ornithine. Therefore, an investigation of reagent type and volume was carried out to obtain better recovery for all the three amino acids. Arginine (AR21), citrulline (CI41), ornithine (OR61), and their internal standards (AR61, CI21, and OR21) were spiked into 50 μL of human plasma. Multiple volumes (two, three, four, five, seven, nine, and eleven times of 50 μL) of acetonitrile, methanol, and isopropanol were used for protein precipitation and the amino acid extraction. One fifth of the supernatant was transferred to a vial. Eighty μL of 5 mM ammonium formate were added into the vial, followed by adding certain amount of acetonitrile, methanol, or isopropanol to reach the final volume of 200 μL. Ten μL of each sample were injected for comparison. The results in Figure 1 indicates that reagent type is a greater factor than volume for the recovery. Around five times of the plasma volume, the performance for arginine is methanol > isopropanol > acetonitrile, for citrulline is methanol ≥ isopropanol > acetonitrile, and for ornithine is methanol > isopropanol ≥ acetonitrile. However, volume is a critical factor as well. The performance of acetonitrile dramatically decreases with the increase of its volume for all the three amino acids. The performance of isopropanol slightly decreases with the increase of its volume all the three amino acids. On the contrary, the performance of methanol stays stable with the increase of its volume all the three amino acids. Based on the performance and consideration of next steps in the sample preparation, 540 μL of methanol (about eleven times of the plasma volume) was chosen for protein precipitation and amino acid extraction. The extraction step was followed by a dilution step. Basically, the developed method is a two-step sample preparation approach. In numerous publications, dryness and resuspension steps are often involved, which requires additional process. In comparison, the two-step sample preparation is simple and superior to other approaches.
MS/MS detection
Choosing product ions of the three amino acids has been diverse in literature.
The product ions of arginine have been chosen as 43.0, 60.0, and 70.0 [11, 12, 17, 18] , the product ions of citrulline have been chosen as 70.1, 113.0, and 159.1 [11, 12, 17, 18] , and the product ions of ornithine have been chosen as 70.0 and 116.1 [11, 17, 18] .
Theoretically, multiple product ions are available for transition monitoring. As long as a transition passes the criteria in a full validation, especially the selectivity and LLOQ, the transition is acceptable. Transitions, retention times, and ionization source parameters for each analyte were listed in Supplemental Method 1. Representative chromatograms of the current LC-MS/MS analysis using the chosen transitions from a patient sample are shown in Figure 2. 
Calibration curve and linearity
The assay validation has been designed to carry out using four methods: water as blank matrix, 1% BSA in PBS as blank matrix, surrogate analyte, and background subtraction. The calibration curves from three consecutive batches using water as blank matrix showed an overall accuracy of 98.3-100.8% with RSD of less than 3.7% for arginine, 99.2-101.0% with RSD of less than 2.9% for citrulline, and 97.3-102.2% with RSD of less than 2.5% for ornithine. The detailed results are shown in Supplemental Table 1 . The calibration curves from three consecutive batches using BSA as blank matrix showed an overall accuracy of 95.3-104.8% with RSD of less than 2.6% for arginine, 98.7-102.6% with RSD of less than 4.1% for citrulline, and 97.3-103.1% with RSD of less than 3.8% for ornithine. The detailed results are shown in Table 1 and Supplemental Table 2 . The calibration curves from three consecutive batches using surrogate analytes showed an overall accuracy of 96.8-104.1% with RSD of less than 3.9% for arginine, 94.5-107.5% with RSD of less than 6.2% for citrulline, and 98.6-103.3% with RSD of less than 3.1% for ornithine. 
Precision and accuracy
The intra-and inter-assay precision and accuracy from the three consecutive batches using water as blank matrix are shown in Supplemental Table 5 . The intraassay accuracy is 88.8-99.3% with RSD of 1.1-3.3% for arginine, 92.5-101.5% with RSD of 0.6-2.9% for citrulline, and 91.9-102.1% with RSD of 1.2-3.5% for ornithine.
The inter-assay accuracy is 90.3-95.3% with RSD of 1.8-4.3% for arginine, 95.3-99.8% with RSD of 1.6-3.8% for citrulline, and 94.5-98.6% with RSD of 2.0-3.8% for ornithine. The intra-and inter-assay precision and accuracy from the three consecutive batches using BSA as blank matrix are shown in Table 2 and Supplemental Table 6 .
The intra-assay accuracy is 90.5-108.0% with RSD of 1. with RSD of 3.3% for ornithine were achieved when the background subtraction was utilized.
Selectivity
Using the first three methods, all the tested six lots of blank matrix samples showed that interference peaks at the retention time of interest either did not exist or satisfied the criteria. Selectivity LLOQs using water as blank matrix obtained an accuracy of 96.0% with an RSD of 2.5% for arginine, 102.0% with an RSD of 1.8% for citrulline, and 106.2% with an RSD of 4.9% for ornithine. Selectivity LLOQs using BSA as blank matrix obtained an accuracy of 105.6% with an RSD of 5.5% for arginine, 108.7% with an RSD of 6.3% for citrulline, and 106.2% with an RSD of 4.9% for ornithine. Selectivity LLOQs using surrogate analytes obtained an accuracy of 90.0%
with an RSD of 3.6% for arginine, 96.2% with an RSD of 4.1% for citrulline, and 101.9%
with an RSD of 2.4% for ornithine. The detailed results are shown in Supplemental Table 13 -15. When the background subtraction method was applied, the selectivity assessment was not applied, because the blank samples had high endogenous levels.
Matrix effect
The detailed matrix effect results are shown in Supplemental Table 16-18. Matrix effect LOQs using water as blank matrix exhibit 0.9% for arginine, 0.5% for the internal standard of arginine, 1.4% for citrulline, 1.4% for the internal standard of citrulline, 2.0% for ornithine, and 2.0% for the internal standard of ornithine. Matrix effect LOQs using BSA as blank matrix exhibit 7.7% for arginine, 6.2% for the internal standard of arginine, -53.9% for citrulline, -53.8% for the internal standard of citrulline, 7.1% for ornithine, and 2.7% for the internal standard of ornithine. Matrix effect LOQs using surrogate analytes exhibit -24.3% for arginine, -25.3% for the internal standard of arginine, -58.3% for citrulline, -58.4% for the internal standard of citrulline, -9.9% for ornithine, and -10.1% for the internal standard of ornithine. All six lots of matrix have showed similar matrix effect for both analytes and their corresponding internal standards. When the background subtraction method was applied, the matrix effect evaluation was not applied, because the blank samples had high endogenous levels.
Recovery
Overall recoveries from low, mid, and high QCs using water as blank matrix were 93.1% for arginine, 95.4% for the internal standard of arginine, 93.8% for citrulline, 91.2% for the internal standard of citrulline, 93.1% for ornithine, and 91.4% for the internal standard of ornithine. The detailed results are shown in Supplemental Table 19 .
Overall recoveries from low, mid, and high QCs using BSA as blank matrix were 85.0% for arginine, 91.5% for the internal standard of arginine, 88.0% for citrulline, 93.8% for the internal standard of citrulline, 83.3% for ornithine, and 90.4% for the internal standard of ornithine. The detailed results are shown in Table 3 . Overall recoveries from low, mid, and high QCs using surrogate analytes were 74.7% for arginine, 78.6% for the internal standard of arginine, 85.8% for citrulline, 91.5% for the internal standard of citrulline, 78.5% for ornithine, and 83.5% for the internal standard of ornithine. The detailed results are shown in Supplemental Table 20 . The results indicate that consistent recoveries at all three QC levels of all analytes and their internal standard have been achieved. When the background subtraction method was applied, the selectivity assessment was not applied, because of the high endogenous levels in blank samples.
Stability
The stability results of the analytes in BSA under different conditions are shown in Table 4 . The accuracy and precision of three freeze/thaw cycles, 48h room temperature storage, and 55 days storage at −60 to −80 •C fit the ± 15% criteria. 
Comparison of the four methods
The four methods, water as blank matrix, 1% BSA in PBS as blank matrix, surrogate analyte, and background subtraction, have been fully validated. The first three methods have been successful in fulfilling all the criteria, while the last one has failed in LLOQs, LOQs, and low concentrations of the calibration curves. The reason is that the blank samples have high endogenous levels. This is one of the two significant issues in the application of background subtraction. It is extremely difficult to obtain a plasma sample that contains the lowest levels of the endogenous analyte. Assuming such a sample as blank matrix is available, any other samples whose endogenous level near the blank matrix sample still face the challenge of accurate quantification, because its LLOQ may not cover these samples. The other significant issue in the application of background subtraction is data processing. Currently, MultiQuant is able to calculate the exogenous level of a spiked analyte by subtracting the endogenous level of the analyte of choice, but considering the endogenous level of the analyte as zero. It works for validation, since exogenous spiking is applied. However, it is not able to obtain the real endogenous level of analytes, because the endogenous level in every sample is subtracted by the endogenous level in the matrix severing as a blank sample, showing that any assay sample having an endogenous level equal or less than the endogenous level in the matrix will be assigned zero or a negative value after the calculation. Some software may be able to process the data differently without zeroing the matrix level.
However, these software are often limited with certain mass spectrometers. Crossing different platforms or data formats commonly is not available for regular users.
Therefore, background subtraction is the last choice of methods for analyzing endogenous analytes.
On the contrary, the first three methods are easily practicable without considering the two issues described above. However, they are still different from each other with advantages and disadvantages. To compare them, cost, data quality, and matrix similarity are considered. Because surrogate analyte method requires additional stable isotope-labeled standards, it is more expensive than the other two methods. When the surrogate analyte method is applied, three transitions need to be monitored rather than two transitions to monitor in the other two methods. Therefore, less scan time is spent on each transition, leading to less accurate peak intensity, especially for low abundance analytes. When multiple analytes are under detection at the same retention time, an additional transition in the three transitions may become a burden. For matrix similarity, the surrogate analyte method has the identical matrix as endogenous analyte does, water is the most unlike matrix, and BSA is in the middle. Generally speaking, BSA is the number one choice, water is the second choice, and the surrogate analyte method is the last one based on the three factors. If cost is not a burden and a high performance mass spectrometer is available with faster scan speed, the surrogate analyte method seems to be a good choice. However, researchers have to examine whether same amount of analyte and surrogate analyte have the same signal response on a mass spectrometer. Unlike exogenous analysis that uses an identical matrix and analyte, endogenous analysis has to use either a surrogate matrix or a surrogate analyte. Therefore, there is no universal rule on whether surrogate matrix or surrogate analyte should be applied. Researchers should consider the cost of labelled analytes, the performance of a mass spectrometer, and the type of matrix comprehensively. A comparison of surrogate matrix and surrogate analyte methods for quantitation of endogenous biomolecules concludes that both assays are well within tolerances prescribed by regulatory guidance for validation, the surrogate analyte approach allows for facile method development, and the surrogate matrix method has the long-term advantage of simplified sample analysis [15] . Another comparison shows that the surrogate analyte in authentic matrix approach performed as well as the authentic analyte in surrogate matrix approach, indicating that the surrogate analyte approach is not required for the accurate quantification of endogenous compounds in complex samples [19] . Mainly, the difference is under 10%. According the EMEA criteria, the measured concentrations have no difference between or among the three methods. The BSA functioned effectively as a blank matrix for these three amino acids, considering cost, data quality, matrix similarity, and practicality.
Conclusion
The developed two-step sample preparation method using methanol as protein precipitation reagent in this study is simple and superior to other approaches. When experimental data excluding its use as a blank matrix is absent, the BSA approach is the best choice among the four methods for an assay application, considering cost, data quality, matrix similarity, and practicality. any two of the methods and RSD value among the three methods were carried out. The results show that he difference between any two methods or among the three methods presents 100% of samples with less than 20% for all the three amino acids. Mainly, the difference is under 10%. Therefore, the measured concentrations in 97 human plasma samples are considered not different between or among the three methods. 
